Closure on Matthew Perry’s Case
The official investigation into the tragic passing of actor Matthew Perry, known for his role in “Friends,” has concluded.
Police in Los Angeles have officially closed the case following the ruling that his death was accidental. The Los Angeles County Medical Examiner-Coroner has also marked the case as closed.
Cause of Death Determination
The cause of Perry’s untimely demise was attributed to the acute effects of ketamine.
The medical examiner’s report identified additional contributing factors, including drowning, coronary artery disease, and the impact of buprenorphine, a drug commonly used in opioid addiction treatment.
Ketamine Effects and Medical Details
Perry’s autopsy revealed substantial levels of ketamine in his system comparable to those of a patient under general anesthesia in a hospital setting.
The medical examiner highlighted that such high levels of ketamine could induce cardiovascular overstimulation and respiratory depression, which likely contributed to his passing.
Context Surrounding His Death
In the days leading up to his demise, Perry had shared a picture on Instagram from the same hot tub where he was later found.
His passing occurred a year after he had openly discussed his battle with addiction in a memoir, where he detailed his struggles and subsequent recovery journey.
Conclusion and Funeral Details
Matthew Perry was laid to rest in a private ceremony attended by his “Friends” co-stars.
Notably, the toxicology report showed no presence of alcohol, cocaine, heroin, meth, or fentanyl in his system, shedding light on the circumstances surrounding his tragic and unexpected death.
Insights into Ketamine Treatment
The medical examiner’s report shed light on Perry’s ketamine infusion therapy for depression, indicating that while the last session occurred days before his death, the timing and duration of the treatment didn’t directly contribute to his passing.
Breaking News
TDPel Media
This article was published on TDPel Media. Thanks for reading!Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn